Diabetes & Endocrinology

Building on the Promise of Radioembolization with Yttrium-90

Yttrium-90 (Y-90) has long been used to treat liver cancer. Researchers are exploring its potential to treat diseases in other sites, but a number of obstacles have made progress halting.


Meeting the Challenge of Transitioning Diabetic Young People to Adult Care

A new transition model benefits teenagers and young adults with Type 1 diabetes who are moving from pediatric to adult care, researchers say.


A Breath of Foul Air: Pollution and Pediatric Diabetes Risk

Research at the University of Southern California has uncovered a link between air pollution and elevated risk of Type 2 diabetes among overweight Latino children.


Pediatric Health in Profile

Physicians and medical researchers face tremendous challenges in the area of pediatrics. Rising rates of obesity and widespread drug use among children can seem like intractable problems. Here are some of the troubling statistics.


Empagliflozin: A Transformative Approach to Diabetes?

A major trial demonstrated the glucose-lowering drug empagliflozin reduces cardiovascular morbidity and mortality in individuals with Type 2 diabetes and existing cardiovascular disease. Clinicians and researchers discuss how it does so and who is most likely to benefit.


Product Spotlight

Nanodiscs Get Personal with Cancer

The immune systems of mice can “remember” cancer cells and provide extended immunity, according to research involving technology that carries individualized vaccines to treat certain tumors.

University of Michigan researchers filled nanodiscs — tiny...


Refining Diet-based Approaches to Lowering Type 2 Diabetes Risk

Not all plant-based foods provide equal benefit in terms of reducing risk of diabetes, a new Harvard study finds.


A Rising Surgical Tide

Bariatric surgery continues to proliferate — and that has significant implications for surgeons who perform the procedures, for physicians who treat obesity-related comorbidities and for plastic surgeons.


Exploring Bariatric Surgery’s Potential as a Diabetes Therapeutic

Two types of bariatric surgery were markedly more effective than lifestyle interventions alone at producing at least partial remission of Type 2 diabetes, according to a recent study. The findings add to the evidence of weight-loss surgery’s effectiveness as a diabetes treatment for certain individuals.


A Step toward Preventing Type 1 Diabetes?

Using an experimental synthetic ROR inverse agonist, SR1001, a team of researchers prevented mouse models from developing Type 1 diabetes.